Cardiac sarcoidosis/diagnostics

ECG and ECHO
It is used to monitor the ongoing status of patients in the screening. In the case of echocardiography, left ventricular hypertrophy is often detected, typically with thinning of the basal septum due to fibrosis. Furthermore, we observe a violation of the systolic / diastolic function of the left ventricle. Sometimes there is also pericardial effusion and signs of pulmonary hypertension.

Magnetic resonance imaging and PET
Magnetic resonance imaging of the heart is indicated to diagnose heart disease and also to stratify the risk of sudden death. A typical finding is late gadolinium enhancement (LGE) of the subepicardial and middle myocardial basal parts of the interventricular septum or the lateral wall of the left ventricle.

PETexamination using 18-FDG is used in the diagnosis of the disease and also to monitor the effect of therapy. The principle is the uptake of 18-FDG by the inflammatory altered myocardium. It is therefore essential that patients undergo preparation prior to this examination (eg  exclusion of sugars 6-12 hours  before examination).

Other investigation methods
Endomyocardial Biopsy] has a low yield  for inhomogeneous distribution (25%), so its routine use is not recommended. It is preferred to perform a biopsy of extracardiac areas in which higher yields and a lower risk of complications are achieved. Endomyocardial biopsy is performed in cases where it is not possible to perform a biopsy of extracardiac areas, and especially when isolated cardiac sarcoidosis is suspected.

Literature

 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".
 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".
 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".
 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".
 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".
 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".
 * ANTON, Jan. Materiály k přednášce "Sarkoidóza".